Utilisation of Chimeric Lyssaviruses to Assess Vaccine Protection against Highly Divergent Lyssaviruses

Utilisation of Chimeric Lyssaviruses to Assess Vaccine Protection against Highly Divergent Lyssaviruses

Lyssaviruses constitute a diverse range of viruses with the ability to cause fatal encephalitis known as rabies. Existing human rabies vaccines and post exposure prophylaxes (PEP) are based on inactivated preparations of, and neutralising antibody preparations directed against, classical rabies viru...

Full description

Bibliographic Details
Main Authors: Jennifer S. Evans, Guanghui Wu, David Selden, Hubert Buczkowski, Leigh Thorne, Anthony R. Fooks, Ashley C. Banyard
Format: Article
Language:English
Published: MDPI AG 2018-03-01
Series:Viruses
Subjects:
lyssavirus
rabies
vaccine
neutralizing antibody
chimera
antigenic
Online Access:http://www.mdpi.com/1999-4915/10/3/130

Internet

http://www.mdpi.com/1999-4915/10/3/130

Similar Items